Patricia Piscina-La
Gasteiz / Vitoria, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry.
Journal: Therapeutic advances in gastroenterology
Published: October 17, 2025
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 31, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2025
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).
Journal: The American journal of gastroenterology
Published: July 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.
Journal: Alimentary pharmacology & therapeutics
Published: June 09, 2024
Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn's disease: a case-control study.
Journal: International journal of colorectal disease
Published: May 27, 2024
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry.
Journal: Digestive diseases (Basel, Switzerland)
Published: September 13, 2023
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Journal: Therapeutic advances in gastroenterology
Published: June 19, 2023
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease.
Journal: United European gastroenterology journal
Published: August 10, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
Journal: Journal of clinical medicine
Published: June 10, 2022
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study].
Journal: Journal of Crohn's & colitis
Published: April 05, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Journal: Inflammatory bowel diseases
Published: September 10, 2021
Last Updated: 09/26/2026